MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease

Burlington, Massachusetts, February 4, 2019 — MilliporeSigma today announced the winners of its Advance Biotech Grantprogram in Europe. The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their therapies to market. Applicants from emerging biotech companies across Europe were asked to describe their projects, the medical needs they solve,... Read more

GE Healthcare and Aga Khan University Hospital Pakistan announce strategic partnership

Dubai, UAE; January 29, 2019: On the sidelines of Arab Health 2019, the region’s leading healthcare exhibition, GE Healthcare and The Aga Khan University Hospital (AKUH) in Karachi, Pakistan, today announced a strategic partnership to give Pakistan’s leading private quaternary care hospital access to a new range of advanced medical imaging and diagnostic equipment. GE... Read more

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue

Basel, 30 January 2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue The Alzheimer’s Prevention Initiative (API) study of crenezumab in familial Alzheimer’s disease continues Roche remains committed to ongoing clinical studies in Alzheimer’s disease, including GRADUATE Phase... Read more

Thermo Fisher Scientific Signs Agreement to Sell its Anatomical Pathology Business

WALTHAM, Mass., Jan. 28, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to sell its Anatomical Pathology business to PHC Holdings Corporation, a global innovator in healthcare solutions, for approximately $1.14 billion in cash. The Anatomical Pathology business is a... Read more

1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution

Powerful Single Cell Bioinformatics Solution in a Graphical User Interface Powerful Single Cell Bioinformatics Solution in a Graphical User Interface ST. LOUIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize... Read more

BIO-TECHNE LAUNCHES CELL AND GENE THERAPY PORTFOLIO

MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ — Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer solutions that advance the translation of cell and gene therapies, from discovery-level research to the optimization of cell therapy manufacturing unit... Read more

Shimadzu announces a New Research Facility to drive innovation further as part of the Shimadzu Technology Research Laboratory expansion.

Shimadzu Corporation has announced plans to build the SHIMADZU Future Collaboratory at the Technology Research Laboratory in Keihanna Science City, Kyoto Prefecture, Japan to expand the program of innovation at Shimadzu Corporation. The new laboratory will further drive research and development by focusing on several core themes including artificial intelligence (AI), innovative biotechnology, brain-science and... Read more

G-CON Manufacturing and GE Healthcare Announce Collaboration to Advance Early-Stage Cell Therapy and Viral Vector Manufacturing

College Station, TX and Chicago, IL, US, January 23 2019 – G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions (“PODs”) and GE Healthcare plan to collaborate to improve cell therapy and viral vector manufacturing by providing drug developers with a combined, flexible, and readily deployable manufacturing platform suitable for early-stage clinical or commercial production.... Read more

Miltenyi Biotec acquires promising non-harmful imaging process

BERGISCH GLADBACH,  Jan 17, 2019 – Miltenyi Biotec GmbH, a global provider of products and services for biomedical research and cellular therapy, announced that it has signed a purchase contract for a non-harmful, fluorescence-preserving, optical clearing process from the University of Duisburg-Essen, Germany. The acquired invention involves an easy-to-use protocol that allows a safe optical clearing... Read more

QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan

Hilden, Germany, and Tokyo, Japan, January 16, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the therascreen® EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer’s VIZIMPRO® (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent... Read more